GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (XTER:0QF) » Definitions » Sale Of Business

Moderna (XTER:0QF) Sale Of Business : €0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Moderna Sale Of Business?

Moderna's sale of business for the three months ended in Mar. 2025 was €0 Mil. It means Moderna gained €0 Mil from selling business. Moderna's sale of business for the trailing twelve months (TTM) ended in Mar. 2025 was €0 Mil.

Compared with last quarter (€0 Mil in Dec. 2024 ), Moderna gained the same money from selling business in Mar. 2025 (€0 Mil).


Moderna Sale Of Business Historical Data

The historical data trend for Moderna's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Sale Of Business Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Business
Get a 7-Day Free Trial Premium Member Only - - - - -

Moderna Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Moderna Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moderna Sale Of Business Related Terms

Thank you for viewing the detailed overview of Moderna's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Moderna Business Description

Address
325 Binney Street, Cambridge, MA, USA, 02139
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna Headlines

No Headlines